Webinar
When Supply Chains Tighten: How Hidden Dependencies Could Reshape MedTech Growth
Submit the form to access the webinar
Register Now
More About the Webinar
What if the biggest constraint on the growth of the 600+ billion dollar MedTech industry isn’t innovation, demand, or political upheaval, but a hidden dependency buried deep within the supply chains?
The rapid globalization of the Global MedTech trade has grown ~7× over the last 30 years. Recent geopolitical disruptions and the global pandemic are fuelling innovation. On the other hand, it also highlighted vulnerabilities that were yet unseen. The industry is currently striving to bridge the gaps created by raw material shocks, sanctions, and semiconductor shortages.
Under this noise, there are some key indicators, like upstream blind spots, geographic dependencies, ESG pressures, and cross-industry competition that could reshape this industry quietly.
However, it is crucial to understand which of these factors will stall and which will accelerate growth. This webinar answers these queries while shedding light on whitespaces, secondary impact, and emerging signals.
Webinar Agenda
- Status Quo: While MedTech supply chains, with 45,000+ firms, appear diversified around the edges, they remain concentrated at the core. Technology has improved forecasting visibility, but hidden dependencies are partially understood. Therefore, a disruption in one node could easily cascade across multiple segments.
- Hidden risk radar (0–2–5 year view): ~45% of Medtech companies wish to diversify supply chains regionally, because next disruptions may not resemble the COVID-19 pandemic, but would be hidden or second-order risks that this webinar will focus on.
- The narrowing decision window: Which proactive course of action will enable leaders to manage and mitigate invisible risks that may sabotage supply chains in the coming years?
- Rethinking resilience vs. efficiency: How are companies responding to second- and third-order risks, and how do strategies like buffers, diversification, or localization create advantage or erode margins?
- Complexity vs. substitutability: While some disruptions could permanently or temporarily break certain systems, others may influence accessibility or increase costs considerably. It's crucial to differentiate one from the other.
Meet the Speakers
Arpit Sharma brings extensive experience in global research, providing crucial insights into innovation, technology, market trends, and competitive landscapes. He is assisting clients in knowledge management, empowering CXOs to make confident, data-driven decisions. With over 400 research assignments for clients in MedTech, Arpit's expertise spans complex data analysis and strategic insights globally. As a technology advisor dedicated to leveraging science to improve technology for humanity, he specializes in bridging the gap between university research and industry, helping organizations and students become “Future Ready.”
Sandhya Saraswat is Manager – Healthcare Innovation Strategy at Stellarix, with over a decade of experience in MedTech, Biotechnology, Diagnostics, and Consumer Healthcare. She specializes in technology consulting, startup and technology scouting, competitive intelligence, portfolio management, and IP analytics. Sandhya helps organizations translate emerging technologies into actionable insights, drive strategic initiatives, and optimize innovation portfolios, enabling informed, data-driven decisions in rapidly evolving healthcare and life sciences landscapes.